816 related articles for article (PubMed ID: 18022078)
21. Bronchial hyperresponsiveness and the bronchiolitis obliterans syndrome after lung transplantation.
Reid DW; Walters EH; Johns DP; Ward C; Burns GP; Liakakos P; Williams TJ; Snell GI
J Heart Lung Transplant; 2005 Apr; 24(4):489-92. PubMed ID: 15797754
[TBL] [Abstract][Full Text] [Related]
22. Effect of adherence to home spirometry on bronchiolitis obliterans and graft survival after lung transplantation.
Kugler C; Fuehner T; Dierich M; DeWall C; Haverich A; Simon A; Welte T; Gottlieb J
Transplantation; 2009 Jul; 88(1):129-34. PubMed ID: 19584692
[TBL] [Abstract][Full Text] [Related]
23. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome.
Shitrit D; Amital A; Fox B; Kramer MR
Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973
[TBL] [Abstract][Full Text] [Related]
24. Successful bilateral lung transplant outcomes in recipients 61 years of age and older.
Palmer SM; Davis RD; Simsir SA; Lin SS; Hartwig M; Reidy MF; Steele MP; Eu PC; Blumenthal JA; Babyak MA
Transplantation; 2006 Mar; 81(6):862-5. PubMed ID: 16570009
[TBL] [Abstract][Full Text] [Related]
25. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
Ross DJ; Marchevsky A; Kramer M; Kass RM
J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
[TBL] [Abstract][Full Text] [Related]
26. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
Dusmet M; Maurer J; Winton T; Kesten S
J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
[TBL] [Abstract][Full Text] [Related]
27. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
[TBL] [Abstract][Full Text] [Related]
28. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
[TBL] [Abstract][Full Text] [Related]
30. Early changes in basement membrane thickness in airway walls post-lung transplantation.
Law L; Zheng L; Orsida B; Levvey B; Oto T; Kotsimbos AT; Snell GI; Williams TJ
J Heart Lung Transplant; 2005 Oct; 24(10):1571-6. PubMed ID: 16210132
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
Kesten S; Chaparro C; Scavuzzo M; Gutierrez C
J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
[TBL] [Abstract][Full Text] [Related]
32. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.
Langenbach SY; Zheng L; McWilliams T; Levvey B; Orsida B; Bailey M; Williams TJ; Snell GI
J Heart Lung Transplant; 2005 Oct; 24(10):1550-6. PubMed ID: 16210129
[TBL] [Abstract][Full Text] [Related]
33. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome.
Borro JM; Bravo C; Solé A; Usetti P; Zurbano F; Lama R; De la Torre M; Román A; Pastor A; Laporta R; Cifrián JM; Santos F
Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206
[TBL] [Abstract][Full Text] [Related]
34. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
[TBL] [Abstract][Full Text] [Related]
35. Long-term clarithromycin therapy in the management of lung transplant recipients.
Benden C; Boehler A
Transplantation; 2009 May; 87(10):1538-40. PubMed ID: 19461491
[TBL] [Abstract][Full Text] [Related]
36. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
[TBL] [Abstract][Full Text] [Related]
37. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
[TBL] [Abstract][Full Text] [Related]
38. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
[TBL] [Abstract][Full Text] [Related]
39. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
[TBL] [Abstract][Full Text] [Related]
40. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]